Cytokines in Cancer Immunotherapy

Cited by (504)

Items 201–300 of 504

1. Closely related reovirus lab strains induce opposite expression of RIG-I/IFN-dependent versus -independent host genes, via mechanisms of slow replication versus polymorphisms in dsRNA binding σ3 respectively
   Adil Mohamed, Prathyusha Konda, Heather E. Eaton, Shashi Ashok Gujar, James R. Smiley, Maya Shmulevitz · 2020 · PLoS Pathogens
2. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
   Aylin Alkan, Tobias Hofving, Eva Angenete, Ulf Yrlid · 2021 · Biomarker Research
3. mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity
   Christopher J. Nirschl, Heather R. Brodkin, Celesztina Domonkos, Connor J. Dwyer, Daniel J. Hicklin, Nesreen S. Ismail, Cynthia Seidel‐Dugan, Philipp Steiner, Zoe Steuert, Jenna M. Sullivan et al. · 2023 · Cancer Immunology Research
4. Current Trends in Messenger RNA Technology for Cancer Therapeutics
   Ali Afzal, Muddasir Hassan Abbasi, Shaaf Ahmad, Nadeem Sheikh, Muhammad Babar Khawar · 2025 · Biomaterials Research
5. Induced proximity at the cell surface
   Nicholas A. Till, Muthukumar Ramanathan, Carolyn Ruth Bertozzi · 2025 · Nature Biotechnology
6. Modulation of T cell function and survival by the tumor microenvironment
   Nikita Lavanya Mani, Dathan Andrews, Rebecca C. Obeng · 2023 · Frontiers in Cell and Developmental Biology
7. In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imaging
   Corby Fink, Julia J. Gevaert, John W. Barrett, Jimmy Dimitrios Dikeakos, Paula J. Foster, Gregory A. Dekaban · 2023 · European Radiology Experimental
8. The mechanism of cytokine regulation of cancer occurrence and development in the tumor microenvironment and its application in cancer treatment: a narrative review
   Run Qu, Yanhong Zhao, Yuzhe Zhang · 2024 · Translational Cancer Research
9. High expression level of interleukin-1β is correlated with poor prognosis and PD-1 expression in patients with lung adenocarcinoma
   Xi Ding, J. Zhang, Mengxuan Shi, D. Liu, L. Zhang, R. Zhang, Bo Su, K. Ai · 2020 · Clinical & Translational Oncology
10. The use of adenoviral vectors in gene therapy and vaccine approaches
    Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura · 2022 · Genetics and Molecular Biology
11. Immunocyte membrane-derived biomimetic nano-drug delivery system: a pioneering platform for tumour immunotherapy
    Yuan-ye Zeng, Qing Gu, Dan Li, Ai-Xue Li, Rongmei Liu, Jianying Liang, Jiyong Liu · 2024 · Acta Pharmacologica Sinica
12. Nanoparticles: Properties and Applications in Cancer Immunotherapy
    Alessandra Iscaro, Faith Hannah Nutter Howard, Munitta Muthana · 2019 · Current Pharmaceutical Design
13. Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy
    Xinmin Wang, Jing Jing · 2025 · MedComm
14. Unlocking the potential of the tumor microenvironment for cancer therapy
    Muhammad Tufail · 2023 · Pathology - Research and Practice
15. Cancer nanomedicine: emergence, expansion, and expectations
    Keerthana Suresh Kizhakkanoodan, Yuvraj Rallapalli, Joyceline Praveena, Sriprasad Acharya, Bharath Raja Guru · 2023 · SN Applied Sciences
16. Cytokine-overexpressing dendritic cells for cancer immunotherapy
    Joonsu Han, Hua Wang · 2024 · Experimental & Molecular Medicine
17. Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses
    Xubiao Wei, Lulu Zhang, Rijun Zhang, Rujuan Wu, James N. Petitte, Yanfei Hou, Dayong Si, Baseer Ahmad, Henan Guo, Manyi Zhang et al. · 2021 · Frontiers in Immunology
18. Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma
    Wenfei Ge, Shiyan Song, Xiaochen Qi, Feng Chen, Xiangyu Che, Yonghao Sun, Jin Wang, Xiaowei Li, Nana Liu, Qifei Wang et al. · 2023 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
19. A self‐assembled, genetically engineered, irradiated tumor cell debris vaccine
    Yajie Sun, Yan Hu, Yuanyuan Geng, Chao Wan, Yang Liu, Yifei Liao, Xiujuan Shi, Jonathan F. Lovell, Kunyu Yang, Honglin Jin · 2024 · Exploration
20. The role of cytokines in shaping the future of Cancer immunotherapy
    Sahar Safaei, AmirHossein Yari, Omid Pourbagherian, Leili Aghebati Maleki · 2025 · Cytokine
21. Immunization of Mice with Gold Nanoparticles Conjugated to Thermostable Cancer Antigens Prevents the Development of Xenografted Tumors
    Lev A. Dykman, Sergey Aleksandrovich Staroverov, Serguei Kozlov, Alexander S. Fomin, Daniil S. Chumakov, К. П. Габалов, Yevgeny S. Kozlov, Dmitry Soldatov, Nikolai G. Khlebtsov · 2022 · International Journal of Molecular Sciences
22. Promising immunotherapy: Highlighting cytokine‐induced killer cells
    Solmaz Shirjang, Nazila Alizadeh, Behzad Mansoori, Ata Mahmoodpoor, Hossein Samadi Kafil, Mohammad Hojjat‐Farsangi, Mehdi Yousefi · 2018 · Journal of Cellular Biochemistry
23. EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy
    Yuanzhuo Gu, Hongchao He, Shilei Qiao, Yifan Shao, Lurong Wang, Zhengkui Zhang, Long Zhang, Fangfang Zhou · 2025 · Advanced Science
24. Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
    Rwaa Hussin Abdulal, Jana S. Malki, Ezdehar Abdulraouf Ghazal, Ahdab Alsaieedi, Sarah A. Almahboub, Muhammad Yasir Khan, Reem M. Alsulaiman, Mazen M. Ghaith, Turki S. Abujamel, Magdah Ganash et al. · 2023 · Frontiers in Molecular Biosciences
25. Immune Checkpoint Inhibitors, Small-Molecule Immunotherapies and the Emerging Role of Neutrophil Extracellular Traps in Therapeutic Strategies for Head and Neck Cancer
    Connor H. O’Meara, Zuhayr Jafri, Levon Michael Khachigian · 2023 · International Journal of Molecular Sciences
26. Development of Recombinant Oncolytic rVSV-mIL12-mGMCSF for Cancer Immunotherapy
    Anastasia Ryapolova, Ekaterina Minskaia, Nizami B. Gasanov, Vasiliy Moroz, Bogdan Krapivin, Alexander D. Egorov, Victor S. Laktyushkin, Sofia Zhuravleva, Maksim Nagornych, Е. Н. Субчева et al. · 2023 · International Journal of Molecular Sciences
27. Nucleic acid cancer vaccines targeting tumor related angiogenesis. Could mRNA vaccines constitute a game changer?
    Srdan Tadic, Alfredo Martı́nez · 2024 · Frontiers in Immunology
28. Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
    Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, Paola Orecchia, Alessandro Delli Poggi, Lorenzo Mortara · 2025 · Vaccines
29. Current Immunotherapy Approaches for Malignant Melanoma
    Jaesung Lim, Eunjin Cho, Kyungwoo Lee, Yonghyun Choi, Youngmin Seo, Hojeong Jeon, Jonghoon H. Choi · 2019 · BioChip Journal
30. Serum proteomic analysis of melanoma patients with immunohistochemical profiling of primary melanomas and cultured cells: Pilot study
    Jan Kučera, Karol�na Strnadov�, Barbora Dvoř�nkov�, Lukáš Lacina, Ivana Krajsov�, Jiří Štork, Hana Kov�řov�, Helena Skaln�kov�, Petr Vodička, Jan Motl�k et al. · 2019 · Oncology Reports
31. Impact of T-cell immunity on chemotherapy response in childhood acute lymphoblastic leukemia
    Yizhen Li, Xu Yang, Yu Sun, Zhenhua Li, Wenjian Yang, Bensheng Ju, John B. Easton, Deqing Pei, Cheng Cheng, Shawn YC Lee et al. · 2022 · Blood
32. Coagulation- and fibrinolysis-related genes for predicting survival and immunotherapy efficacy in colorectal cancer
    Yanling Ma, Bofang Wang, Puyi He, Wenbo Qi, Ling Xiang, Ewetse Paul Maswikiti, Hao Chen · 2022 · Frontiers in Immunology
33. Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapy
    Yusuke Inoue, Naoki Inui, Masato Karayama, Kazuhiro Asada, Masato Fujii, Shun Matsuura, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Masaki Ikeda et al. · 2023 · Cancer Immunology Immunotherapy
34. Sleep loss impairs blood-brain barrier function: Cellular and molecular mechanisms
    Jessica J. Avilez-Avilez, María Fernanda Medina Flores, Beatriz Gómez‐González · 2024 · Vitamins and hormones
35. Revolutionizing cancer treatment: the rise of personalized immunotherapies
    Amna Fayyaz, Aleena Haqqi, Rashid Khan, Muhammad Irfan, Khushbukhat Khan, Željko Reiner, Javad Sharifi‐Rad, Daniela Cornelia Călina · 2024 · Discover Oncology
36. New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity
    Arthur Μ. Krieg · 2025 · Journal for ImmunoTherapy of Cancer
37. Association of functional IL16 polymorphisms with cancer and cardiovascular disease: a meta-analysis
    Victor Hugo de Souza, Josiane Bazzo de Alencar, Bruna Tiaki Tiyo, Hugo Vicentin Alves, Evelyn Castillo Lima Vendramini, Ana Maria Sell, Jeane Eliete Laguila Visentainer · 2020 · Oncotarget
38. NIR‐II Light Powered Asymmetric Hydrogel Nanomotors for Enhanced Immunochemotherapy
    Yingfei Wang, Wei Chen, Zhong Wang, Yu Zhu, Hongxia Zhao, Kun Wu, Jie Wu, Weihua Zhang, Qing Zhang, Hongqian Guo et al. · 2022 · Angewandte Chemie
39. Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
    Xiaoyu Mao, Fanglong Song, Ju Jin, Bin Zou, Peijun Dai, Mingjuan Sun, Weicheng Xu, Lianghua Wang, Yifan Kang · 2023 · Frontiers in Immunology
40. Therapeutic applications of RNA nanostructures
    Theresa Yip, Xiaodong Qi, Hao Yan, Yung Chang · 2024 · RSC Advances
41. Inflammation-associated drug resistance and tumor growth in TNBC
    Arij Fouzat Hassan, Hadeel Kheraldine, Lama Abujamous, Hamda Al-Thawadi, Abdelbary M. A. Elhissi · 2025 · Frontiers in Immunology
42. Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumours
    Lindsay K. Dickerson, Jason A. Carter, Karan Kohli, Venu Gopal Pillarisetty · 2023 · Gut
43. Predictive value of serum cytokines in patients with non-small-cell lung cancer receiving anti-PD-1 blockade therapy: a meta-analysis
    Qian Liu, Zakari Shaibu, Aiguo Xu, Fang Yang, Ruoxue Cao, Fumeng Yang · 2025 · Clinical and Experimental Medicine
44. Interleukin-21 engineering enhances CD19-specific CAR-NK cell activity against B-cell lymphoma via enriched metabolic pathways
    Bailin He, Hong Chen, Jiaxu Wu, Shiqiu Qiu, Qiusui Mai, Qing Zeng, Cong Wang, Shikai Deng, Zihong Cai, Xiaoli Liu et al. · 2025 · Experimental Hematology and Oncology
45. The Heterogeneity of Infiltrating Macrophages in Metastatic Osteosarcoma and Its Correlation with Immunotherapy
    Zhanchao Wang, Huiqiao Wu, Yu Chen, Huajiang Chen, Wen Yuan, Xinwei Wang · 2021 · Journal of Oncology
46. Association of CTLA-4 and IL-4 polymorphisms in viral induced liver cancer
    Maria Shabbir, Yasmin Badshah, Khushbukhat Khan, Janeen H. Trembley, Areeb Rizwan, Fatima Faraz, Syeda Alveena Shah, Mahrukh Farooqi, Naeem Mahmood Ashraf, Tayyaba Afsar et al. · 2022 · BMC Cancer
47. Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review
    Chao Wang, Meng Yuan, Yongjian Gao, Ruizhi Hou, Defeng Song, Ye Feng · 2023 · Oncology Research and Treatment
48. Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models
    Regina Lin, Janette E. Sutton, Trevor Bentley, Diego A. Vargas‐Inchaustegui, Duy Nguyen, Hsin‐Yuan Cheng, Hayung Yoon, Thomas J. Van Blarcom, Barbra Johnson Sasu, Siler H. Panowski et al. · 2023 · Science Advances
49. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p
    Ehsan Gharib, Leili Rejali, Moein Piroozkhah, Elham Zonoobi, Parinaz Nasri Nasrabadi, Zahra Arabsorkhi, Kaveh Baghdar, Elahe Shams, Amir Sadeghi, Peter J.K. Kuppen et al. · 2024 · Journal of Translational Medicine
50. Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
    Mohsen Nabi‐Afjadi, Samane Ostadhadi, Mahsa Liaghat, Ajay Prakash Pasupulla, Sajjad Masoumi, Fatemeh Aziziyan, Hamidreza Zalpoor, Leila Abkhooie, Vahideh Tarhriz · 2024 · Biomedicine & Pharmacotherapy
51. Tracking inflammation status for improving patient prognosis: A review of current methods, unmet clinical needs and opportunities
    Vidya Raju, Revanth Reddy, Arzhang Cyrus Javan, Behnam Hajihossainlou, Ralph Weissleder, Anthony Guiseppi‐Elie, Katsuo Kurabayashi, Simon A. Jones, Rose T. Faghih · 2025 · Biotechnology Advances
52. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives
    Huan Xu, Mingyang Shi, Changsheng Shao, Hao Li, Jing Wu, Yin Yu, Fang Fang, Yugang Guo, Weihua Xiao · 2021 · Microbial Cell Factories
53. Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
    Hongfei Zhu, Feifei Mao, Kang Wang, Jinkai Feng, Shuqun Cheng · 2022 · Frontiers in Genetics
54. Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
    Randy F. Sweis, Yuanyuan Zha, Lomax F. Pass, Brian L. Heiss, Tara Chongsuwat, Jason J. Luke, Thomas Frank Gajewski, Russell Zelig Szmulewitz · 2018 · Journal for ImmunoTherapy of Cancer
55. Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model
    Donia Alson, Scott C. Schuyler, Bo-Xin Yan, Karthika Samimuthu, Jian-Tai Timothy Qiu · 2020 · Frontiers in Immunology
56. Advances in mRNA‐Lipid Nanoparticle Engineering for Immune Cell Targeting and Immune Modulation
    Cheesue Kim, Yeji Lee, Hyukjin Lee, Byung‐Soo Kim · 2025 · Small Methods
57. Breast neoplasm epithelial-mesenchymal transition and cytokines: a systematic review
    Yi‐An Chen, Haining Ding, Jiaqing Song, Xiufei Gao · 2025 · Cancer Cell International
58. Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes
    Dan Zheng, Xiaolin Hou, Jing Yu, Xiujing He · 2022 · Frontiers in Pharmacology
59. SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy
    John K. Cini, Susan Dexter, Darrel J. Rezac, Stephen J. McAndrew, Gaël Hédou, Rich Brody, Rukiye-Nazan Eraslan, Richard T. Kenney, Pankaj Mohan · 2023 · Frontiers in Immunology
60. Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18
    Yan Cheng, Yuanhui Zhao, Yu Liu, Yichi Zhang, Dongge Xu, Weikang Sun, Mengyu Zhang, Yuqing Miao, Susu He, Yayi Hou et al. · 2024 · Journal for ImmunoTherapy of Cancer
61. Emerging Frontiers in Colorectal Cancer Therapy: From Targeted Molecules to Immunomodulatory Breakthroughs and Cell-Based Approaches
    Nayeralsadat Fatemi, Seyedeh Nasim Mirbahari, Sascha Tierling, Fatemeh Sanjabi, Shabnam Shahrivari, Mandana AmeliMojarad, Melika AmeliMojarad, Meygol Mirzaei Rezaei, Parsa Nobaveh, Mehdi Totonchi et al. · 2025 · Digestive Diseases and Sciences
62. Is AAV-delivered IL-27 a potential immunotherapeutic for cancer?
    Jin-Qing Liu, Jianmin Zhu, Aiyan Hu, Alaina Zhang, Chunbaixue Yang, Jianyu Yu, Kalpana Ghoshal, Sujit Basu, Xue‐Feng Bai · 2020 · PubMed Central
63. Impact of noncoding RNAs on cancer directed immune therapies: Now then and forever
    Roshan Kumar Roy, Rakhi Yadav, Uttam Sharma, Mishi Kaushal Wasson, Ashok Kumar Sharma, Pranay Tanwar, Aklank Jain, Hridayesh Prakash · 2022 · International Journal of Cancer
64. Saga of monokines in shaping tumour-immune microenvironment: Origin to execution
    Naveen Challagundla, Dhruvi Shah, Shivani Yadav, Reena Agrawal-Rajput · 2022 · Cytokine
65. Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma
    Junwen Shen, Rongjiang Wang, Yu Chen, Zhihai Fang, Jianer Tang, Jianxiang Yao, Jianguo Gao, Xiaonong Chen, xinli shi · 2023 · Aging
66. Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors
    Chirine Rafia, Christelle Harly, Emmanuel Scotet · 2020 · Immunological Reviews
67. The Bioinformatics-Based Analysis Identifies 7 Immune-Related Genes as Prognostic Biomarkers for Colon Cancer
    Jie Pan, Zongqi Weng, Chaorong Xue, Bing-qiang Lin, Mengxin Lin · 2021 · Frontiers in Oncology
68. Reversing vemurafenib‐resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects
    Alessandra Fragale, Emilia Stellacci, Giulia Romagnoli, Valerio Licursi, Stefania Parlato, Irene Canini, Giacomo Remedi, Maria Buoncervello, Paola Matarrese, Lucia Pedace et al. · 2023 · International Journal of Cancer
69. Interleukins and interferons in mesenchymal stromal stem cell-based gene therapy of cancer
    Urban Švajger, Urška Kamenšek · 2024 · Cytokine & Growth Factor Reviews
70. Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects
    Chaofan Chen, Pengfei Yuan, Zhiyun Zhang · 2024 · Frontiers in Immunology
71. Systemic immunostimulation induces glucocorticoid-mediated thymic involution succeeded by rebound hyperplasia which is impaired in aged recipients
    Craig P. Collins, Lam T. Khuat, Gail D. Sckisel, Logan Vahid Vick, Christine Mall Minnar, Cordelia Dunai, Catherine T. Le, Brendan D. Curti, Marka R. Crittenden, Alexander A. Merleev et al. · 2024 · Frontiers in Immunology
72. Recent advances in AIE-based platforms for cancer immunotherapy
    Ziyi Chen, Xue‐Ping Li, Qian Liu, Wen Li, Tianjiao Wang, Dan Ding · 2024 · Journal of Controlled Release
73. Natural Killer Cell‐Mediated Antitumor Immunity: Molecular Mechanisms and Clinical Applications
    Nanzhi Luo, Cong Chen, Wenjing Zhou, Jianqi Hao, Song He, Yu Liu, Yin Ku, Linhua Huang, Chuanfen Zhang, Yueli Shu et al. · 2025 · MedComm
74. Research advances of secretory proteins in malignant tumors
    Na Zhang, Jia‐Jie Hao, Yan Cai, Ming‐Rong Wang · 2021 · Chinese Journal of Cancer Research
75. Immunotherapy: A new target for cancer cure (Review)
    Fuqian Zhao, Dao-fu Shen, Mingquan Shang, Hao Nao Yu, Xiaoxue Zuo, Lixin Chen, Zhijin Huang, Lianxing Li, Lei Wang · 2023 · Oncology Reports
76. IL12/18/21 Preactivation Enhances the Antitumor Efficacy of Expanded γδT Cells and Overcomes Resistance to Anti–PD-L1 Treatment
    Huey Yee Teo, Yuan Song, Kylie Su Mei Yong, Yonghao Liu, Yu Mei, Zuhairah Binte Hanafi, Ying Zhu, Yen Leong Chua, Nicholas R. J. Gascoigne, Qingfeng Chen et al. · 2023 · Cancer Immunology Research
77. Advances in engineering and delivery strategies for cytokine immunotherapy
    Margaret Bohmer, Yonger Xue, Katarina E. Jankovic, Yizhou Dong · 2023 · Expert Opinion on Drug Delivery
78. The role of intestinal flora on tumor immunotherapy: recent progress and treatment implications
    Yimin Zhou, Xiangdong Liu, Wei Gao, Xin Luo, Junying Lv, Yunshan Wang, Duanrui Liu · 2023 · Heliyon
79. Emerging IL-12-based nanomedicine for cancer therapy
    Zeyuan Xin, Shuai Qu, Yunfeng Qu, Yunxue Xu, Renfa Liu, Desheng Sun, Zhifei Dai · 2024 · Nano Today
80. Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF
    Heung Jin Jeon, Daejin Lim, EunA So, Solbi Kim, Jae‐Ho Jeong, Miryoung Song, Hyo Jin Lee · 2024 · Acta Pharmaceutica Sinica B
81. Natural killer cell memory: challenges and opportunities for cancer immunotherapy
    Yuhua Qu, Anhui Zeng, Yulu Cheng, Shengchun Li · 2024 · Cancer Biology & Therapy
82. Siglec-15 antibody–GM-CSF chimera suppresses tumor progression via reprogramming tumor-associated macrophages
    Zemeng Ma, Xiaoyao Hao, Shuang Qu, Quanli Zhang, Jiajing Luo, Hongyan Li, Jinyu Liu, Wenwen Dai, Jun Li, Shouyong Gu et al. · 2025 · Journal for ImmunoTherapy of Cancer
83. Advances and challenges in cancer immunotherapy: Strategies for personalized treatment
    Mahir Azmal, Md. Munna Miah, Fatema Sultana Prima, Jibon Kumar Paul, ANM Shah Newaz Been Haque, Ajit Ghosh · 2025 · Seminars in Oncology
84. Advancing Cancer Immunotherapy Using Lipid Nanoparticle-Based Approaches
    Pedro Henrique Dias Moura Prazeres, Gabriel Costa da Silva, Giovane Azevedo, Natália Jordana Alves da Silva, Pedro Augusto Carvalho Costa, Walison da Silva, Anderson Oliveira Lobo, Pedro Pires Goulart Guimarães · 2025 · International Journal of Nanomedicine
85. Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19
    Santosh Kumar Singh, Rajesh Singh · 2022 · Cells
86. Drug Repurposing by Tumor Tissue Editing
    Florian Lüke, Dennis Christoph Harrer, Pan Pantziarka, Tobias Pukrop, Lina Ghibelli, Christopher Gerner, Albrecht Reichle, Daniel Heudobler · 2022 · Frontiers in Oncology
87. Revitalizing Cytokine‐Based Cancer Immunotherapy through Advanced Delivery Systems
    Pengwen Chen, West Kristian D. Paraiso, Horacio Cabral · 2023 · Macromolecular Bioscience
88. Overview of Basic Immunology and Clinical Application
    Bettzy Stephen, Joud Hajjar · 2020 · Advances in experimental medicine and biology
89. Novel classes of immunotherapy for breast cancer
    Alberto Hernando‐Calvo, David W. Cescon, Philippe Lucien Bedard · 2021 · Breast Cancer Research and Treatment
90. Prognostic role of serum cytokines level in non-small cell lung cancer patients with anti-PD-1 and chemotherapy combined treatment
    Hongyu Liu, Chao Zhou, Haohua Jiang, Tianqing Chu, Runbo Zhong, Xueyan Zhang, Yinchen Shen, Baohui Han · 2024 · Frontiers in Immunology
91. Advances in Liposomal Interleukin and Liposomal Interleukin Gene Therapy for Cancer: A Comprehensive Review of Preclinical Studies
    Eman A. Kubbara, Ahmed Kamal Bolad, Husam M. Malibary · 2025 · Pharmaceutics
92. Overcoming cancer immunotherapy barriers via nanomaterial-mediated pyroptosis
    Jianlei Xie, Baoxin Peng, Yu Xiao, Xiasang Chen, Xinying Zhang, Diqi Chen, Lijuan Song, Meiqian Xu, Wenjing Liao, Xiaowen Zhang · 2025 · Journal of Materials Chemistry B
93. The “double-edged sword” effect of cytokines in cancer: coexisting opportunities and challenges
    Xuan Yin, Wangzheqi Zhang, Guanhua Wang, Yawei Liu, Bing Dai, Liping Yue · 2025 · Frontiers in Immunology
94. Bioengineering strategies to enhance the interleukin-18 bioactivity in the modern toolbox of cancer immunotherapy
    Mojtaba Taheri, Hossein Abdul Tehrani, Fatemeh Daliri, Mona Alibolandi, Masoud Soleimani, Alireza Shoari, Ehsan Arefian, Mohammad Ramezani · 2023 · Cytokine & Growth Factor Reviews
95. Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment
    Taylor R. Jamieson, Joanna Poutou, Carolina S. Ilkow · 2020 · Cytokine & Growth Factor Reviews
96. Evaluation of the clinical application value of cytokine expression profiles in the differential diagnosis of prostate cancer
    Rongfa Chen, Linna Liu, Hui Chen, Chao Xing, Tingting Zhang, Yilin Pang, Xunjun Yang · 2024 · Cancer Immunology Immunotherapy
97. Localized Nano-mediated Interleukin-12 Gene Therapy: Promising Candidate for Cancer Immunotherapeutics
    Moganavelli Singh, Jeaneen Venkatas · 2022 · Current Cancer Drug Targets
98. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-MUC1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies
    Johanna Gellert, Anika Jaekel, Antje Danielczyk, Christoph Goletz, Timo Lischke, Anke Flechner, Laura Dix, Alexandra Günzl, Patrik Kehler · 2024 · International Journal of Molecular Sciences
99. Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises
    Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, Noushin Nabavi, Amir Reza Aref, Salman Daneshi, Alireza Razzaghi, Maryam Abedi, Safa Tahmasebi, Najma Farahani et al. · 2025 · Pathology - Research and Practice
100. Electrotransfer of IL-15/IL-15Rα Complex for the Treatment of Established Melanoma
     Shawna A. Shirley, Cathryn G. Lundberg, Richard F. Heller · 2020 · Cancers